FM
Family Management Portfolio holdings
AUM
$658M
1-Year Return
14.42%
This Quarter Return
+7.27%
1 Year Return
+14.42%
3 Year Return
+54.25%
5 Year Return
+91.79%
10 Year Return
+224.62%
AUM
$145M
AUM Growth
-$856K
(-0.59%)
Cap. Flow
-$9.28M
Cap. Flow
% of AUM
-6.39%
Top 10 Holdings %
Top 10 Hldgs %
50.37%
Holding
80
New
12
Increased
19
Reduced
25
Closed
10
Top Buys
| 1 |
Johnson & Johnson
JNJ
|
+$3.79M |
| 2 |
Amazon
AMZN
|
+$3.45M |
| 3 |
Acadia Pharmaceuticals
ACAD
|
+$550K |
| 4 |
Berkshire Hathaway Class A
BRK.A
|
+$500K |
| 5 |
RPT
Rithm Property Trust Inc.
RPT
|
+$496K |
Top Sells
| 1 |
Gilead Sciences
GILD
|
+$4.01M |
| 2 |
SVC
Service Properties Trust
SVC
|
+$2.44M |
| 3 |
Macy's
M
|
+$2.25M |
| 4 |
XLNX
Xilinx Inc
XLNX
|
+$1.63M |
| 5 |
Howmet Aerospace
HWM
|
+$1.32M |
Sector Composition
| 1 | Technology | 24.41% |
| 2 | Healthcare | 12.64% |
| 3 | Consumer Discretionary | 12.25% |
| 4 | Communication Services | 11.58% |
| 5 | Financials | 11.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
American Express
AXP
$226B
| $1.79M | 1.23% |
22,645
-1,226
| -5% | -$97K |
|
27
Visa
V
$668B
| $1.66M | 1.14% |
18,711
-2,500
| -12% | -$222K |
|
28
Toll Brothers
TOL
$14B
| $1.4M | 0.96% |
38,763
-5,287
| -12% | -$191K |
|
|
29
Acadia Pharmaceuticals
ACAD
$4.19B
| $1.22M | 0.84% |
35,500
+16,000
| +82% | +$550K |
|
|
KATE
30
DELISTED
Kate Spade & Company
KATE
| $1.16M | 0.8% |
50,000
| – | – |
|
31
Meta Platforms (Facebook)
META
$1.92T
| $1.02M | 0.7% |
7,187
-500
| -7% | -$71K |
|
32
Citigroup
C
$179B
| $780K | 0.54% |
13,037
-1,107
| -8% | -$66.2K |
|
|
33
Berkshire Hathaway Class A
BRK.A
$1.06T
| $750K | 0.52% |
3
+2
| +200% | +$500K |
|
|
34
Berkshire Hathaway Class B
BRK.B
$1.06T
| $674K | 0.46% |
4,043
+1,993
| +97% | +$332K |
|
35
Bristol-Myers Squibb
BMY
$96.1B
| $569K | 0.39% |
10,455
| – | – |
|
|
RPT
36
Rithm Property Trust Inc.
RPT
$125M
| $496K | 0.34% |
+39,309
| New | +$496K |
|
37
Lineage Cell Therapeutics
LCTX
$290M
| $477K | 0.33% |
158,158
+26,713
| +20% | +$80.6K |
|
38
Stryker
SYK
$150B
| $474K | 0.33% |
3,600
+1,600
| +80% | +$211K |
|
39
Chevron
CVX
$312B
| $432K | 0.3% |
4,020
| – | – |
|
40
Altria Group
MO
$111B
| $429K | 0.3% |
6,008
+614
| +11% | +$43.8K |
|
41
AT&T
T
$210B
| $413K | 0.28% |
13,171
+4,392
| +50% | +$138K |
|
42
Enterprise Products Partners
EPD
$68.3B
| $363K | 0.25% |
13,147
+372
| +3% | +$10.3K |
|
43
Philip Morris
PM
$256B
| $360K | 0.25% |
3,192
-636
| -17% | -$71.7K |
|
44
Amgen
AMGN
$151B
| $328K | 0.23% |
2,000
| – | – |
|
45
Merck
MRK
$211B
| $326K | 0.22% |
5,383
| – | – |
|
46
Walt Disney
DIS
$211B
| $296K | 0.2% |
2,614
-80
| -3% | -$9.06K |
|
|
NYMTO
47
DELISTED
New York Mortgage Trust, Inc. 7.875% Series C Cumulative Redeemable Preferred Stock
NYMTO
| $291K | 0.2% |
+12,210
| New | +$291K |
|
48
Energy Transfer Partners
ET
$58.9B
| $276K | 0.19% |
14,000
| – | – |
|
49
Pfizer
PFE
$140B
| $274K | 0.19% |
8,432
+45
| +0.5% | +$1.46K |
|
50
BioMarin Pharmaceuticals
BMRN
$10.7B
| $263K | 0.18% |
3,000
| – | – |
|